1,2-Dichloroethane → tert-butyl (4S,7S,10aS)-5-oxo-7-(propylcarbamoyl)octahydro-2H-pyrido[2,1-b][1,3]thiazepin-4-ylcarbamate
Reaction equation
CCN(C(C)C)C(C)C.[C:10]([O:14][C:15]([NH:17][C@H:18]1[CH2:24][CH2:23][S:22][C@H:21]2[CH2:25][CH2:26][CH2:27][C@@H:28]([C:29](O)=[O:30])[N:20]2[C:19]1=[O:32])=[O:16])([CH3:13])([CH3:12])[CH3:11].[CH2:33]([NH2:36])[CH2:34][CH3:35].ON1C2N=CC=CC=2N=N1.C(Cl)CCl>CN(C=O)C>[O:32]=[C:19]1[C@@H:18]([NH:17][C:15](=[O:16])[O:14][C:10]([CH3:12])([CH3:11])[CH3:13])[CH2:24][CH2:23][S:22][C@H:21]2[CH2:25][CH2:26][CH2:27][C@@H:28]([C:29](=[O:30])[NH:36][CH2:33][CH2:34][CH3:35])[N:20]12Participants
Reactant 5
Product 1
Reagents, catalysts & solvents 1
Procedure
DIPEA (0.033 mL, 0.19 mmol) was added to a cold (0° C.) mixture of (4S,7S,10aS)-4-(tert-butoxycarbonylamino)-5-oxooctahydro-2H-pyrido[2,1-b][1,3]thiazepine-7-carboxylic acid (50 mg, 0.15 mmol), propan-1-amine (10.3 mg, 0.174 mmol) and 1-hydroxy-7-azabenzotriazole (23.7 mg, 0.174 mmol) in DMF (0.3 mL). Then, EDC (33.4 mg, 0.174 mmol) was added. The reaction was stirred at rt for 8 hr. The crude mixture was purified by RP prep-HPLC (Method B) to give tert-butyl (4S,7S,10aS)-5-oxo-7-(propylcarbamoyl)octahydro-2H-pyrido[2,1-b][1,3]thiazepin-4-ylcarbamate (56 mg, 0.15 mmol, 100% yield) as a white solid. Anal. Calcd. for C18H31N3O4S m/z 385.5. found: 386.2 (M+H)+. 1H NMR (400 MHz, CDCl3) δ ppm 6.02 (br s, 1H), 5.27 (br s, 1H), 5.02 (br s, 1H), 4.77 (m, 1H), 3.23 (m, 2H), 2.89 (m, 1H), 2.36 (m, 1H), 2.41 (m, 2H), 2.05 (m, 2H), 1.53-1.50 (m, 6H), 1.50 (s, 9H), 0.90 (t, J=7.5 Hz, 3H).
Workup
- customThe crude mixture was purified by RP prep-HPLC (Method B)
Sources & evidence
- ORD record
- ord-00683b47361f44ca8d9b1389f50f1fc6
- Source dataset
- uspto-grants-2016_05
- Patent number
- US09346852B2
Reaction notes
Loading…